NDC 17856-1123-01 - MAX relief junior Grape
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 17856-1123
- Requested NDC
- 17856-1123-01
- Package NDCs from labels
- 17856-1123-5, 17856-1123-1, 17856-1123-6, 17856-1123-2, 17856-1123-7, 17856-1123-3, 17856-1123-8, 17856-1123-4, 17856-1123-9, 17856-1123-01
- Manufacturer
- ATLANTIC BIOLOGICALS CORP.
- Effective date
- 2026-05-05
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| MAX relief junior Grape - ATLANTIC BIOLOGICALS CORP. | ATLANTIC BIOLOGICALS CORP. | 2026-05-05 | HUMAN OTC DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 17856-1123-1 | MAX relief junior Grape | 72 in 1 BOX, UNIT-DOSE | LIQUID | 72 | 3 | |
| 17856-1123-2 | MAX relief junior Grape | 48 in 1 BOX, UNIT-DOSE | LIQUID | 48 | 3 | |
| 17856-1123-3 | MAX relief junior Grape | 48 in 1 BOX, UNIT-DOSE | LIQUID | 48 | 3 | |
| 17856-1123-4 | MAX relief junior Grape | 120 in 1 BOX, UNIT-DOSE | LIQUID | 120 | 3 | |
| 17856-1123-5 | MAX relief junior Grape | 5 mL in 1 CUP, UNIT-DOSE | LIQUID | 5 | 3 | |
| 17856-1123-6 | MAX relief junior Grape | 5 mL in 1 SYRINGE | LIQUID | 5 | 3 | |
| 17856-1123-7 | MAX relief junior Grape | 7.5 mL in 1 SYRINGE | LIQUID | 7.5 | 3 | |
| 17856-1123-8 | MAX relief junior Grape | 2.5 mL in 1 SYRINGE | LIQUID | 2.5 | 3 | |
| 17856-1123-9 | MAX relief junior Grape | 1.25 mL in 1 SYRINGE | LIQUID | 1.25 | 3 | |
| 17856-1123-9 | MAX relief junior Grape | 120 in 1 BOX, UNIT-DOSE | LIQUID | 120 | 3 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 17856-1123 | MAX RELIEF JUNIOR GRAPE (CHILDRENS ACETAMINOPHEN) LIQUID [ATLANTIC BIOLOGICALS CORP.] | 2 | Current NDC, 10 package rows | 20250514_c60494f0-5a50-41da-bcb4-88178ded54b7.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 17856-1123-1 | ML - Milliliter | 17856-1123 | 8388e1a5-2288-4cdd-8d9f-c5b459666af6 | 1 | 2026-02-05 |
| 17856-1123-2 | ML - Milliliter | 17856-1123 | 5393c6f3-a727-4ae2-b0b0-476db34ca660 | 1 | 2026-02-05 |
| 17856-1123-5 | ML - Milliliter | 17856-1123 | dd17b560-546e-4dc7-88c6-218a6d830b68 | 1 | 2026-03-17 |
| 17856-1123-6 | ML - Milliliter | 17856-1123 | 2415504e-c35a-411d-89b0-bf6cb341f6f2 | 1 | 2026-02-05 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Vicks DayQuil Intense Flu Rapid Release LiquiCaps | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE | The Procter & Gamble Manufacturing Company | 4cd4213c-7569-32da-e063-6294a90a5695 | 2026-10-09 | Warnings | 362O9ITL9D |
| Vicks NyQuil Intense Flu Rapid Release LiquiCaps | ACETAMINOPHEN, DOXYLAMINE SUCCINATE, DEXTROMETHORPHAN HBR | The Procter & Gamble Manufacturing Company | 354906d1-455b-460c-8283-984e73c09d7e | 2026-10-09 | Warnings | 362O9ITL9D |
| Vicks NyQuil SINUS PAIN and HEADACHE | ACETAMINOPHEN, DOXYLAMINE SUCCINATE | The Procter & Gamble Manufacturing Company | 4c4ca296-ea6c-1f19-e063-6294a90a8161 | 2026-10-09 | Warnings | 362O9ITL9D |
| Vicks Formula 44 DM Painful Cough and Sore Throat | ACETAMINOPHEN, DEXTROMETHORPHAN HBR | The Procter & Gamble Manufacturing Company | d536f159-304f-4759-be14-0e4895777c97 | 2026-10-09 | Warnings | 362O9ITL9D |
| Vicks Sinex Severe PAIN, MUCUS and CHEST CONGESTION | ACETAMINOPHEN, GUAIFENESIN | The Procter & Gamble Manufacturing Company | 5605aab6-6074-0a3b-e063-6294a90a49a2 | 2026-10-09 | Warnings | 362O9ITL9D |
| infants pain fever | ACETAMINOPHEN | H E B | 1da89528-f658-4103-8041-cee4c775d73f | 2026-10-09 | Warnings | M013 307668 362O9ITL9D |
| Topcare Migraine Relief | ACETAMINOPHEN, ASPIRIN, CAFFEINE | Topco Associates LLC | a2a9fbec-639f-4002-aa34-51b4563fc38e | 2026-10-09 | Warnings | 362O9ITL9D |
| aspirin | ASPIRIN | Meijer Distribution Inc | 338aea3b-a38f-424f-9006-3ede3825bf90 | 2026-10-09 | Warnings | M013 |
| infants pain fever | ACETAMINOPHEN | H E B | ab8ecc76-9621-4acc-b59b-fcf6cb2e52ef | 2026-10-09 | Warnings | M013 307668 362O9ITL9D |
| Complete Cold Relief | ACETAMINOPHEN, DEXTROMETHORPHAN HBR, GUAIFENESIN, PHENYLEPHRINE HCL | Belmora LLC | a81fc021-9a9f-4cec-a1a6-73e3f983b78d | 2026-10-08 | Warnings | 362O9ITL9D |
| butalbital and acetaminophen | BUTALBITAL AND ACETAMINOPHEN | Granules Pharmaceuticals Inc. | 2091c292-b77b-4ce6-8bba-436c74eee3d7 | 2026-10-08 | Boxed warning, Warnings, Adverse reactions | 362O9ITL9D |
| Acetaminophen and Ibuprofen | ACETAMINOPHEN AND IBUPROFEN | Granules Pharmaceuticals Inc. | 0f8b9524-8fe3-47cf-bacd-93047442d90d | 2026-10-08 | Warnings | 362O9ITL9D |
| ACETAMINOPHEN | ACETAMINOPHEN | Granules Pharmaceuticals Inc. | d5352861-6926-f1b0-e053-2a95a90a7d66 | 2026-10-08 | Warnings | 362O9ITL9D |
| ACETAMINOPHEN | ACETAMINOPHEN | Granules Pharmaceuticals Inc. | d5d49146-665e-4a93-e053-2995a90aca59 | 2026-10-08 | Warnings | M013 362O9ITL9D |
| Acetaminophen and Ibuprofen Back Pain | ACETAMINOPHEN AND IBUPROFEN | Granules Pharmaceuticals Inc. | 32562aa1-f44b-649e-e063-6394a90a47c8 | 2026-10-08 | Warnings | 362O9ITL9D |
| Oxycodone and Acetaminophen | OXYCODONE AND ACETAMINOPHEN | Granules Pharmaceuticals Inc. | cc966d57-7cdc-4de3-bbcf-718e2fce9cb7 | 2026-10-08 | Boxed warning, Warnings, Adverse reactions | 362O9ITL9D |
| Hydrocodone Bitartrate and Acetaminophen | HYDROCODONE BITARTRATE AND ACETAMINOPHEN | Granules Pharmaceuticals Inc. | 136bbd47-7a54-493f-9158-a84d39221d6c | 2026-10-08 | Boxed warning, Warnings, Adverse reactions | 362O9ITL9D |
| Aspirin | ASPIRIN | PD-Rx Pharmaceuticals, Inc. | 98c30922-c48c-471a-a72e-50020a11da98 | 2026-10-08 | Warnings | M013 |
| Mejoralito | ACETAMINOPHEN | OPMX | 5a963a92-e29d-05ba-e063-6394a90a3a47 | 2026-10-08 | Warnings | M013 307668 362O9ITL9D |
| Pentrexcilina | ACETAMINOPHEN | OPMX LLC | 5a98e123-8e28-6732-e063-6394a90a010c | 2026-10-08 | Warnings | M013 307668 362O9ITL9D |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.